Predictive factors for fibroids recurrence after uterine artery embolisation

Authors: Marret, Henri1; Cottier, Jean Philippe2; Alonso, Ana Maria1; Giraudeau, Bruno3; Body, Gilles1; Herbreteau, Denis2

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 112, Number 4, April 2005 , pp. 461-465(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objectives 

To assess clinical failure and symptom recurrence after uterine artery embolisation (UAE) and to define predictive factors. Design 

Prospective study of a case series. Setting 

Gynaecology and radiology departments of a French University Hospital. Population 

Eighty-five women who underwent embolisation for the treatment of uterine fibroids. Method 

Vascular access was obtained via the right common femoral artery. Free-flow embolisation was performed using 150–250 μm polyvinyl alcohol particles and an absorbable particle sponge. Main outcome measures 

Clinical failure was defined as persistence of symptoms at three months of follow up and recurrence as return of symptoms. The main outcome measure was the need for further treatment after UAE. Results 

Results are available for 81 patients. Median follow up was 30 months. There were 15 clinical failures and recurrences requiring further treatment (eight hysterectomies, five hysteroscopic resections for submucous fibroids, one second embolisation and one woman refusing further treatment). Recurrence-free survival rate at 30 months (no clinical failure, no recurrence) was 82.8% (95% CI 73.7–91.8%). Multivariate analysis identified two predictive factors: dominant fibroid size on ultrasound imaging (each 1 cm increase: HR = 1.68, 95% CI 1.10–2.69) and number of fibroids (each additional fibroid: HR = 1.34, 95% CI 1.08–1.66). Conclusions 

Symptom recurrence rate 30 months after fibroid embolisation was 17.2%. Fibroid size and number were predictive factors for recurrence. As most recurrences occurred after two years, we recommend that patients be monitored clinically and that imaging be for more than two years after UAE.

Document Type: Research article

DOI: 10.1111/j.1471-0528.2004.00487.x

Affiliations: 1: Department of Gynaecology, Obstetrics, Fetal Medicine and Human Reproduction, Bretonneau University Hospital, Tours, France 2: Department of Neuroradiology, Bretonneau University Hospital, Tours, France 3: Clinical Research Centre, Faculty of Medicine, F. Rabelais, Tours, France

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A